off
Shire Offers $30 Billion for Baxter Spinoff
Dublin-based pharmaceutical group Shire said today it had bid Dollars 30 billion (27 billion euros) for US rival Baxalta to form a global biotech company focused on rare diseases. Shire said its unsolicited all-share offer valued each Baxalta share at $45.23, based on August. 3...
Posted On Aug 04 2015
